{"title": "PDF", "author": "PDF", "url": "https://partnersinpediatrics.com/wp-content/uploads/2022/06/COVID-19-Vaccine-Updated-Pfizer-Administration-form.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "No Health Screening Questions Yes NoDon't Know 1. Are you or your child sick today or have a fever? 2. Have you or your child had an allergic reaction to polysorbate, polyethylene glycol, or a previous dose of COVID- 19 vaccine? 3. Have you or your child ever had a serious allergic reaction (anaphylaxis) to another vaccine or any injectable medication? 4. Have you or your child had severe allergic reaction (anaphylaxis) to foods, pets, venom, environmental or oral medications? 5. Doyou or your child have a bleeding disorder, are on long-term aspirin therapy, or take other blood thinners? 6. Have you or your child ever had Guillain -Barr\u00e9 Syndrome (a type of temporary severe muscle weakness) after receiving a vaccine? 7. Have you received any dermal fillers (Juvaderm\u00ae, Restylane\u00ae, etc.)? (only applies to mRNA vaccines) 8. Do you have a history of blood clots or have risk factors for developing blood clots? ( Janssen vaccine only, applies to females ages 18-49) 9. Do you or your child have a history of myocarditis or pericarditis? (Especially males ages 12- 29 years after receiving a dose of mRNA vaccine) 10. Do you or your child have a history of heparin -induced thrombocytopenia (HIT)? 11. Do you or your child have a history of Multisystem Inflammatory Syndrome known as MIS -C (in children) or MIS -A (in adults) after a COVID -19 infection? 12. Are you or your child immunocompromised? (See additional dose section on next page)Please complete ALL the information below as accurately as possible .If you are completing this form for your minor child, do not use nick -names or abbreviations, except where allowed. All information will be kept confidential. Patient/Child Last Name Patient/Child First Name M.I. Please print neatly in capital letters as shown in the example: CityColorado COVID -19 Vaccine Screening and Administration Form 05/20/2022StateY Y M M D D Y Y CountyParent Last Name ZipCode Medicaid Medicare Kaiser Permanente Other Private NoInsuranceInsurance Policy Number (OPTIONAL -INSURANCE NOT REQUIRED FOR VACCINATION) If youhave already received your Primary Dose(s) of a COVID -19 vaccine , please tell us which vaccine(s ) you received a nd the date(s)of vaccination. Dose(s)received: Dose 1: Vaccine Brand__________ Vaccination Date ______/_____/______ | Dose 2: Vaccine Brand__________ Vaccination Date ______/_____/______Health InsuranceAre you Hispanic/Latin/a/o/x?Please answer all questions as completely as possible. Please use only black ink to complete form.The administration record is on the reverse side of this document. Patient/Representative Daytime Phone Number - - Continued on Next PageGender Identity F M Transgender Female/Feminine -specified Decline ofBirth Age (years) Parent First Name E-mail AddressIf under 18 years of age please complete Yes Decline to ProvideRace(s) check all that apply American Indian/Alaskan Native AsianBlack, African AmericanNative Hawaiian/Pacific IslanderOtherWhite Address Apt.Number Decline to Provide United Healthcare If youhave already received more than two (2) doses of a COVID -19 vaccine , please tell us which additional dose(s) you received, the vaccine(s), a nd the date(s)of vaccination. Additional Dose received for High Risk Conditions :Vaccine Brand__________ Vaccination Date ______/_____/______ Booster Dose: Vaccine Brand__________ Vaccination Additional Booster Vaccine Brand__________ Vaccination Date ______/_____/______Age (months)Pfizer (Orange Cap ) (ages 5 -11 years) Pediatric Primary and 0.2 ml Booster DoseDate ofBirth M M D D Y Y Y YPrimary Dose : 1 2 3 Booster Dose: 1 2* Age (years)Patient/Child Last Name Patient/Child First Name M.I. Authorization to Administer COVID -19 Vaccine I have read or had explained to me the Fact Sheet for Recipients and Caregivers for the use of the COVID -19 vaccine and understand the benefits and risks to me or my child of receiving this vaccine . I have had a chance to ask questions, which were answered to my satisfaction. I hereby release this provider, its employees and its volunteers from any liability for any results which may occur from the administration of thisvaccine. Signature of Patient/ Parent/Legal Guardian / Medical Durable Power of Attorney : Date: ______/_______/_________ Age ( months) For vaccine administration guidance, including: timing, dosing, site selection, needle length and gauge, and administration p rocedures, please reference your standing orders or the FDA for 2nd booster dose is as follows: A second booster dose of either the Pfizer -BioNTech COVID -19 Vaccine or Moderna COVID -19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved C OVID-19 vaccine. A second booster dose of the Pfizer -BioNTech COVID -19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromising conditions at least 4 months after receipt of a first booster dose of any authorized or approved COVID -19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise. A second booster dose of the Moderna COVID -19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID -19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise. *Additional Guidance for J &J Vaccine use: Assess persons 18 years of age and older for vaccination with Janssen COVID_19 Vaccine based on the following criteria: mRNA COVID -19 Vaccines are preferred over Janssen COVID -19 Vaccine for primary series and booster vaccination Inform all persons receiving a Janssen vaccine of the risks and symptoms of thrombosis with thrombocytopenia syndrome (TTS) in the 3 weeks after vaccination as was as the need to seek immediate care should symptoms develop . Janssen COVID -19 Vaccine may be offered in some situations: A true contraindication to mRNA vaccines (severe allergic reaction to a previous dose or a component of the vaccine The person would otherwise remain unvaccinated for COVID-19 due to limited access to mRNA vaccine The person wants to receive the Janssen COVID -19 vaccine despite the safety concerns identifiedPfizer (Maroon Cap ) (ages 6 mo. -4 years) Pediatric Primary Dose 0.2 ml Pfizer 0.3 ml Moderna 0.25 ml J&J 0.5 ml Provider Type Public PrivateClinic Name Pfizer 0.3 ml (age 12 years +) Moderna 0.5 ml (age 18 years +) J&J 0.5 ml (age 18 years +)Primary Dose Site LD LT RD RTDate Administered M M D D Y Y Y Y/ / Name _______________________________________ Title __________Administered by :Lot NumberCOVID/VFC PIN Provider Name Brand Name Booster Dose Moderna (ages 6 mo. -5 years) Pediatric Primary Dose 0.25 ml "}